Jeffrey M. Jonas, President & CEO at Sage Therapeutics, Inc. (SAGE), bought 7,500 shares at $64.20 ($482K) on 2019-12-09, disclosed to the SEC on 2019-12-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | SELL | 2019-05-29 | $29.9M | — | Filing → |